Serological Response in Lung Transplant Recipients after Two Doses of SARS-CoV-2 mRNA Vaccines

Background: Lung-transplant (LT) recipients are at high risk for COVID-19 due to immunosuppression and respiratory tropism of SARS-CoV-2. The information on the effect of COVID-19 mRNA vaccines to elicit immunogenic responses after a two-dose (2D) regimen in LT recipients is sparse. Thus, we assesse...

Descripción completa

Detalles Bibliográficos
Autores principales: Narasimhan, Madhusudhanan, Mahimainathan, Lenin, Clark, Andrew E, Usmani, Amena, Cao, Jing, Araj, Ellen, Torres, Fernando, Sarode, Ravi, Kaza, Vaidehi, Lacelle, Chantale, Muthukumar, Alagarraju
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8310345/
https://www.ncbi.nlm.nih.gov/pubmed/34208884
http://dx.doi.org/10.3390/vaccines9070708

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8310345/
https://www.ncbi.nlm.nih.gov/pubmed/34208884
http://dx.doi.org/10.3390/vaccines9070708

Ejemplares similares